0001209191-23-043137.txt : 20230721 0001209191-23-043137.hdr.sgml : 20230721 20230721170850 ACCESSION NUMBER: 0001209191-23-043137 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230719 FILED AS OF DATE: 20230721 DATE AS OF CHANGE: 20230721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JIMENEZ JOSEPH CENTRAL INDEX KEY: 0001199095 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40532 FILM NUMBER: 231103120 MAIL ADDRESS: STREET 1: ADITUM BIO STREET 2: 1111 BROADWAY, STE. 1300 CITY: OAKLAND STATE: CA ZIP: 94607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Graphite Bio, Inc. CENTRAL INDEX KEY: 0001815776 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 844867570 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 HASKINS WAY, SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 484-0886 MAIL ADDRESS: STREET 1: 201 HASKINS WAY, SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Integral Medicines, Inc. DATE OF NAME CHANGE: 20200622 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-19 0 0001815776 Graphite Bio, Inc. GRPH 0001199095 JIMENEZ JOSEPH C/O GRAPHITE BIO, INC. 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Stock Option (right to buy) 2.72 2023-07-19 4 A 0 20000 0.00 A 2033-07-18 Common Stock 20000 20000 D The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. /s/ Zed Zduniak, attorney-in-fact 2023-07-21